Editorial issue 326

The 3 first papers of this 326th issue of NDT-E  were recently published in NDT. In the first one, JA van den Brand et al  report on "Lifetime risk of renal replacement therapy in Europe: a population-based study using data from the ERA-EDTA Registry". Next, H Izzedine H et al report on 2Renal effects of immune checkpoint inhibitors". And J Boucquemont et al deal with "Identifying subgroups of renal function trajectories2. Again 3 topics of definite current interest.
The last 2 papers were recently published in CKJ. Prendecki M et al  report on 2Long-term outcome in biopsy-proven acute interstitial nephritis treated with steroids". Next S  Lundberg  et al  report on "B cell–depleting therapy with rituximab or ofatumumab in immunoglobulin A nephropathy or vasculitis with nephritis".

CME lectures   
The 3 CME lectures of this issue all deal with amyloidosis. Pr. Sanjeev Sethi (Rochester, MN, USA) reviews "Diagnosis of amyloidosis – the easy and the not so easy diagnosis".
Pr. Helen Lachmann (London, UK) reviews "Promising new treatments of amyloidosis".
Finally, Pr. Jolanta Malyszko (Bialystok, Poland) discusses "Amyloidosis - not so rare but underappreciated problem in nephrology".

Enjoy NDT-Edu!

Let me wish you and yours all the best for a successful year 2017, in every respect (professional, personal, familial).

Prof. Michel Jadoul
Editor-in-Chief NDT-Educational